This study aims to explore the potential predictive effects of MAML3 and MCM6 expression, in addition to known histopathological features, SDHB, S100, and the Ki-67 proliferation index, in forecasting metastatic disease in PCC and PGL. This evidence concerns the gene MAML3 and metastatic neoplasm.